The GlioDAO Mission
Brain cancer remains one of the most challenging forms of cancer, with limited treatment options and poor survival prognosis. Despite its severity, current funding and research efforts fall short of what is needed. Even incremental advances could lead to significant breakthroughs in treatment methods and patient outcomes.
GlioDAO's objective is to unite a global community in the fight against brain cancer by leveraging blockchain technology to democratize funding decisions, drive innovative research, and incentivize the decentralized collection of patient data, paving the way for breakthrough diagnostics and treatments.
6.9%
Current 5-year survival rate for Glioblastoma
0
Approved treatments considered curative
$3.1B
Brain tumor therapeutics market size
$204,284
Average cost of GBM care in the US
Partnered with the best:
Featured Projects
LDL Receptor Appearance as a Diagnostic Early Detector
Cancers feed on Lipoprotein particles from the blood stream and bring these "food particles" into their cells by increasing the number of receptors. Early research has shown widespread Low Density Lipoprotein Receptor (LDLR) expression in microscopic slides of brain tumor samples.
Machine Learning-Assisted Early Detection
The recent development of digital whole slide scanners makes AI-based histopathological image analysis feasible and helps to diagnose cancer by accurately counting cell types and/or quantitative analysis.
Assessing GBM Isolation Through Digital Phenotyping
This study investigates how social isolation and loneliness affect glioblastoma (GBM) patients and their caregivers. GBM is a severe brain cancer that often leads to substantial physical limitations
Contact & Socials
Join a Working Group
Interested in contributing your unique expertise to our organization? Join our slack and introduce yourself!
Join Our Community
Connect with a thriving community of researchers, patients, and supporters. Together, we're working towards groundbreaking discoveries!